217 related articles for article (PubMed ID: 27367588)
1. Hypoxic-Preconditioned Bone Marrow Stem Cell Medium Significantly Improves Outcome After Retinal Ischemia in Rats.
Roth S; Dreixler JC; Mathew B; Balyasnikova I; Mann JR; Boddapati V; Xue L; Lesniak MS
Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3522-32. PubMed ID: 27367588
[TBL] [Abstract][Full Text] [Related]
2. Delayed administration of bone marrow mesenchymal stem cell conditioned medium significantly improves outcome after retinal ischemia in rats.
Dreixler JC; Poston JN; Balyasnikova I; Shaikh AR; Tupper KY; Conway S; Boddapati V; Marcet MM; Lesniak MS; Roth S
Invest Ophthalmol Vis Sci; 2014 Apr; 55(6):3785-96. PubMed ID: 24699381
[TBL] [Abstract][Full Text] [Related]
3. Bone-marrow mesenchymal stem-cell administration significantly improves outcome after retinal ischemia in rats.
Mathew B; Poston JN; Dreixler JC; Torres L; Lopez J; Zelkha R; Balyasnikova I; Lesniak MS; Roth S
Graefes Arch Clin Exp Ophthalmol; 2017 Aug; 255(8):1581-1592. PubMed ID: 28523456
[TBL] [Abstract][Full Text] [Related]
4. Hypoxic conditioned medium derived from bone marrow mesenchymal stromal cells protects against ischemic stroke in rats.
Jiang RH; Wu CJ; Xu XQ; Lu SS; Zu QQ; Zhao LB; Wang J; Liu S; Shi HB
J Cell Physiol; 2019 Feb; 234(2):1354-1368. PubMed ID: 30076722
[TBL] [Abstract][Full Text] [Related]
5. Hypoxic preconditioning increases the protective effect of bone marrow mesenchymal stem cells on spinal cord ischemia/reperfusion injury.
Wang Z; Fang B; Tan Z; Zhang D; Ma H
Mol Med Rep; 2016 Mar; 13(3):1953-60. PubMed ID: 26783161
[TBL] [Abstract][Full Text] [Related]
6. Hypoxic preconditioning enhances the therapeutic potential of the secretome from cultured human mesenchymal stem cells in experimental traumatic brain injury.
Chang CP; Chio CC; Cheong CU; Chao CM; Cheng BC; Lin MT
Clin Sci (Lond); 2013 Feb; 124(3):165-76. PubMed ID: 22876972
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis and caspases after ischemia-reperfusion injury in rat retina.
Lam TT; Abler AS; Tso MO
Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):967-75. PubMed ID: 10102294
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effects of granulocyte colony-stimulating factor on ischemia-reperfusion injury of the retina.
Shima C; Adachi Y; Minamino K; Okigaki M; Shi M; Imai Y; Yanai S; Takahashi K; Ikehara S
Ophthalmic Res; 2012; 48(4):199-207. PubMed ID: 22868688
[TBL] [Abstract][Full Text] [Related]
9. XIAP-mediated neuroprotection in retinal ischemia.
Renwick J; Narang MA; Coupland SG; Xuan JY; Baker AN; Brousseau J; Petrin D; Munger R; Leonard BC; Hauswirth WW; Korneluk RG; Tsilfidis C
Gene Ther; 2006 Feb; 13(4):339-47. PubMed ID: 16307001
[TBL] [Abstract][Full Text] [Related]
10. Preconditioning provides complete protection against retinal ischemic injury in rats.
Roth S; Li B; Rosenbaum PS; Gupta H; Goldstein IM; Maxwell KM; Gidday JM
Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):777-85. PubMed ID: 9538885
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effect of small interfering RNA targeted to caspase-3 on rat retinal ganglion cell loss induced by ischemia and reperfusion injury.
Ishikawa S; Hirata A; Nakabayashi J; Iwakiri R; Okinami S
Curr Eye Res; 2012 Oct; 37(10):907-13. PubMed ID: 22642649
[TBL] [Abstract][Full Text] [Related]
12. Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice.
Wei N; Yu SP; Gu X; Taylor TM; Song D; Liu XF; Wei L
Cell Transplant; 2013; 22(6):977-91. PubMed ID: 23031629
[TBL] [Abstract][Full Text] [Related]
13. Donor heart preservation with hypoxic-conditioned medium-derived from bone marrow mesenchymal stem cells improves cardiac function in a heart transplantation model.
Zhou P; Liu H; Liu X; Ling X; Xiao Z; Zhu P; Zhu Y; Lu J; Zheng S
Stem Cell Res Ther; 2021 Jan; 12(1):56. PubMed ID: 33435991
[TBL] [Abstract][Full Text] [Related]
14. GDNF gene therapy attenuates retinal ischemic injuries in rats.
Wu WC; Lai CC; Chen SL; Sun MH; Xiao X; Chen TL; Tsai RJ; Kuo SW; Tsao YP
Mol Vis; 2004 Feb; 10():93-102. PubMed ID: 14961006
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of pioglitazone on retinal ischemia/reperfusion injury in rats.
Zhang XY; Xiao YQ; Zhang Y; Ye W
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):3912-21. PubMed ID: 23557740
[TBL] [Abstract][Full Text] [Related]
16. The paracrine effect of cobalt chloride on BMSCs during cognitive function rescue in the HIBD rat.
Dai Y; Li W; Zhong M; Chen J; Cheng Q; Liu Y; Li T
Behav Brain Res; 2017 Aug; 332():99-109. PubMed ID: 28576310
[TBL] [Abstract][Full Text] [Related]
17. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis.
Hu X; Yu SP; Fraser JL; Lu Z; Ogle ME; Wang JA; Wei L
J Thorac Cardiovasc Surg; 2008 Apr; 135(4):799-808. PubMed ID: 18374759
[TBL] [Abstract][Full Text] [Related]
18. Müller cells in the preconditioned retinal ischemic injury rat.
Nishiyama T; Nishukawa S; Hiroshi ; Tomita ; Tamai M
Tohoku J Exp Med; 2000 Aug; 191(4):221-32. PubMed ID: 11038014
[TBL] [Abstract][Full Text] [Related]
19. Deleterious role of TNF-alpha in retinal ischemia-reperfusion injury.
Berger S; Savitz SI; Nijhawan S; Singh M; David J; Rosenbaum PS; Rosenbaum DM
Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3605-10. PubMed ID: 18660426
[TBL] [Abstract][Full Text] [Related]
20. Mouse models of retinal ischemic tolerance.
Zhu Y; Ohlemiller KK; McMahan BK; Gidday JM
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1903-11. PubMed ID: 12036997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
